Document record · 2026-08-27
HistoricalLFS-RT3 · 60 mg
Public record identifying sample, lot, laboratory, method and reported result.
Each report corresponds to a specific lot. Check the lot number on the label against the number published in this record.
Product
LFS-RT3
Presentation
60 mg
Lot or sample
Red Cap
Laboratory
Freedom Diagnostics
Certificate
Accession 2608240539
Date
2026-08-27
Method
HPLC-UV coupled with mass spectrometry (LC-MS); LAL assay (USP <85>)
Reported result
Identidad confirmada (GLP RT); pureza vial 1: 99.97%, vial 2: 99.95% (99.96%); contenido neto vial 1: 65.83 mg, vial 2: 64.76 mg (65.30 mg); endotoxinas réplica 1 y 2: Pass; apariencia polvo liofilizado blanco.
This public copy contains privacy redactions: supplier-identifying details were covered. Analytical results, laboratory attribution and test context are preserved intact.
Documentation for lot Red Cap. It covers only the analyzed sample.
Limit: this record represents the identified sample and presentation. It does not imply universal coverage nor replace verification of the received material.
Other reports for this product
- LFS-RT3 · 30 mg · 2026-07-23View record
- LFS-RT3 · 20 mg · 2026-07-11View record
- LFS-RT3 · 20 mg · 2026-06-24View record
- LFS-RT3 · 10 mg · 2026-06-18View record
- LFS-RT3 · 10 mg · 2026-06-05View record
- LFS-RT3 · 20 mg · 2026-03-02View record